These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15049586)

  • 21. Why does the Bonn Risk Index discriminate between calcium oxalate stone formers and healthy controls?
    Kavanagh JP; Laube N
    J Urol; 2006 Feb; 175(2):766-70. PubMed ID: 16407047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Urolithiasis in hemodialysis patients].
    Nutahara K; Higashihara E
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():370-3. PubMed ID: 15250327
    [No Abstract]   [Full Text] [Related]  

  • 23. A novel method of imaging calcium urolithiasis using fluorescence.
    Figueiredo JL; Passerotti CC; Sponholtz T; Nguyen HT; Weissleder R
    J Urol; 2008 Apr; 179(4):1610-4. PubMed ID: 18295253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Purine loading test in calcium-oxalate stone formers (author's transl)].
    Lux B; Braun J; May P
    Urologe A; 1982 May; 21(3):147-9. PubMed ID: 7201700
    [No Abstract]   [Full Text] [Related]  

  • 25. [Extended metabolic diagnosis of urolithiasis].
    Laube N; Bradenahl J; Thomas E; Meissner A; Müller SC
    Aktuelle Urol; 2006 Nov; 37(6):436-42; quiz 423-4. PubMed ID: 17099832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Etiology and medical management of urinary stone disease.
    Merhej S; Kanso C
    J Med Liban; 2004; 52(4):210-2. PubMed ID: 16432983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of stones in neurological patients.
    Joyce AD
    Curr Opin Urol; 2007 Mar; 17(2):141-3. PubMed ID: 17285026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urolithiasis--medical therapies.
    Spernat D; Kourambas J
    BJU Int; 2011 Nov; 108 Suppl 2():9-13. PubMed ID: 22085119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concurrent urinary tract infection and stone disease: pathogenesis, diagnosis and management.
    Thomas B; Tolley D
    Nat Clin Pract Urol; 2008 Dec; 5(12):668-75. PubMed ID: 19050709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of cellular oxalate in oxalate clearance of patients with calcium oxalate monohydrate stone formation and normal controls.
    Oehlschläger S; Fuessel S; Meye A; Herrmann J; Froehner M; Albrecht S; Wirth MP
    Urology; 2009 Mar; 73(3):480-3. PubMed ID: 19167040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cats and calcium oxalate: strategies for managing lower and upper tract stone disease.
    Palm C; Westropp J
    J Feline Med Surg; 2011 Sep; 13(9):651-60. PubMed ID: 21872792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of high and low calcium diets on stone forming risk during liberal oxalate intake.
    Matsumoto ED; Heller HJ; Adams-Huet B; Brinkley LJ; Pak CY; Pearle MS
    J Urol; 2006 Jul; 176(1):132-6. PubMed ID: 16753387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A form of premorbid condition of urolithiasis and urinary stone composition in children with urolithiasis].
    Jung A; Kamińska A; Olszewski S; Rutka J
    Pol Merkur Lekarski; 2000 Apr; 8(46):188-90. PubMed ID: 10897606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Medical treatment of urinary lithiasis].
    Cachat F; Barbey F; Daudon M
    Rev Med Suisse Romande; 2004 Aug; 124(8):461-4. PubMed ID: 15495468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Jejunoileal bypass reversal: effect on renal function, metabolic parameters and stone formation.
    Dhar NB; Grundfest S; Jones JS; Streem SB
    J Urol; 2005 Nov; 174(5):1844-6; discussion 1846. PubMed ID: 16217311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology, Pathogenesis and diagnosis of calcium oxalate urolithiasis.
    Vahlensieck EW; Bach D; Hesse A; Strenge A
    Int Urol Nephrol; 1982; 14(4):333-47. PubMed ID: 7182367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effects of the active constituents of Alisma orientalis on renal stone formation and bikunin expression in rat urolithiasis model].
    Cao ZG; Liu JH; Zhou SW; Wu W; Yin CP; Wu JZ
    Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1276-9. PubMed ID: 15387965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal colic and recurrent urinary calculi. Management and prevention.
    Laerum E; Murtagh J
    Aust Fam Physician; 2001 Jan; 30(1):36-41. PubMed ID: 11211710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urolithiasis in patients with spinal cord injuries: risk factors, management, and outcomes.
    Ost MC; Lee BR
    Curr Opin Urol; 2006 Mar; 16(2):93-9. PubMed ID: 16479211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.